Unaudited Financial Results For the Half Year Ended 30th September 2025 Together with the Limited review report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shanmuga Hospital Limited reported flat revenue of about ₹2,462 lakhs for H1 FY26 (ended Sep 30, 2025), nearly unchanged from ₹2,462 lakhs in H1 FY25. Profit After Tax came in at ₹201.13 lakhs, down roughly 16% from ₹239.29 lakhs a year ago, mainly due to higher employee costs and depreciation after the company's February 2025 IPO. Total expenses rose to ₹2,202 lakhs from ₹2,159 lakhs. The IPO proceeds (₹2,062 lakhs) were fully utilised during the half-year, with about ₹1,453 lakhs going into capital expenditure, lifting fixed assets sharply from ₹2,243 lakhs to ₹3,763 lakhs. The auditor (PPNand & Company) issued a clean, unqualified limited review report.
Flat top line and a mid-teens drop in profits signal near-term margin pressure for shareholders, but strong operating cash flow (₹2,013 lakhs) and completed IPO capex spending suggest the company is investing for future growth rather than facing structural trouble.